Skip to main content

Table 4 Toxicity of the potential inhibitors from pkCSM server

From: Prospect into therapeutic potentials of Moringa oleifera phytocompounds against cancer upsurge: de novo synthesis of test compounds, molecular docking, and ADMET studies

Compound ID

AMES toxicity

hERG I inhibitor

hERG II inhibitor

Hepatotoxicity

Skin sensitization

ML2

No

No

No

No

No

ML4

No

No

No

Yes

Yes

ML5

No

No

No

No

Yes

ML6

No

No

No

No

Yes

ML7

No

No

Yes

No

Yes

ML8

No

No

No

No

Yes

ML9

No

No

No

No

No

ML10

No

No

Yes

No

Yes

ML11

No

No

No

Yes

Yes

ML12

No

No

No

No

Yes

ML13

No

No

No

No

No

ML14

No

No

No

No

Yes

ML15

No

No

Yes

No

No

MS1

No

No

No

No

Yes

MS2

No

No

No

No

No

MS3

No

No

No

No

Yes

MS4

No

No

No

Yes

Yes

MS5

No

No

Yes

No

Yes

Compound ID

MTD (Human) Log (mg/kg/day)

LD50 (mol/kg)

LOAEL Log (mg/kg_bw/day)

T.pT Log (µg/L)

MT Log (mM)

ML2

0.486

1.573

2.366

0.597

0.522

ML4

0.739

1.967

1.947

1.131

0.893

ML5

0.081

2.118

2.015

1.690

0.205

ML6

0.021

1.534

1.120

2.065

− 0.850

ML7

0.133

1.603

1.043

1.903

− 1.590

ML8

1.178

1.635

2.998

1.935

− 1.373

ML9

0.328

2.754

3.415

0.285

− 6.020

ML10

0.133

1.603

1.043

1.903

− 1.590

ML11

− 0.943

1.604

3.251

0.366

− 1.438

ML12

0.228

1.725

2.815

2.120

− 1.744

ML13

0.442

2.552

0.529

0.285

− 13.725

ML14

0.085

1.503

1.122

2.010

− 1.236

ML15

1.236

1.332

2.733

0.676

− 3.150

MS1

0.178

1.635

2.998

1.935

− 1.373

MS2

0.328

2.754

3.415

0.285

− 6.020

MS3

0.040

1.637

3.075

1.529

− 1.727

MS4

− 0.943

1.604

3.251

0.366

− 1.438

MS5

− 0.245

1.773

0.920

1.637

− 1.120

  1. AMES mutagenicity, hERG human ether-a-go-go gene, MTD maximum tolerated dose, LD50 oral rat acute toxicity, LOAEL oral rat chronic toxicity, T.pT T. pyriformis Toxicity, MT minnow toxicity